Document Detail


Probiotics and Necrotizing Enterocolitis.
MedLine Citation:
PMID:  25459784     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
One of the most controversial areas in neonatology is whether probiotics should be provided routinely to preterm infants to prevent necrotizing enterocolitis (NEC). This review provides the reader with a brief overview of NEC and current concepts of its pathophysiology, discusses the microbial ecology of the intestine in preterm infants and factors that may lead to a "dysbiosis", summarizes studies of probiotics in preterm infants, elaborates on the need for regulation in this area, and discusses alternatives to probiotics and what is the future for the prevention of NEC.
Authors:
Josef Neu
Related Documents :
3215294 - The nature and properties of squirrel lens yellow pigment.
3262444 - Analysis of the causes of maternal death in china.
22375624 - Birth by cesarean section is associated with elevated neonatal plasma levels of dimethy...
21600804 - Human papillomavirus in infants: transmission, prevalence, and persistence.
7197774 - Quantitative morphometric analysis of the pulmonary arteries in two patients with d-tra...
16765684 - Zone 1 retinopathy of prematurity in a transitional economy: a cautionary note.
Publication Detail:
Type:  REVIEW     Date:  2014-9-30
Journal Detail:
Title:  Clinics in perinatology     Volume:  41     ISSN:  1557-9840     ISO Abbreviation:  Clin Perinatol     Publication Date:  2014 Dec 
Date Detail:
Created Date:  2014-12-2     Completed Date:  -     Revised Date:  2014-12-3    
Medline Journal Info:
Nlm Unique ID:  7501306     Medline TA:  Clin Perinatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  967-978     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of Cell-Free Fetal DNA in Maternal Plasma for Noninvasive Prenatal Screening.
Next Document:  Informing and Educating Parents About the Risks and Outcomes of Prematurity.